Psychedelics American DEA boosts psychedelic drug production quotas The agency increases production every year as domestic research demands escalate Rowan DunneJanuary 6, 2026
Bitcoin The year 2025 in review: A Mugglehead roundup Innovation created new avenues for wealth creation, but also exposed structural weaknesses and human error Joseph MortonDecember 30, 2025
Psychedelics Conor McGregor is the latest fighter using psychedelics for healing He recently received ibogaine therapy at a Mexican retreat centre Rowan DunneNovember 25, 2025
Psychedelics Researchers to start FDA-approved study on ‘Jedi Mind Fuck’ psilocybin It is a first-of-its-kind trial in the U.S. on whole mushrooms for PTSD Rowan DunneNovember 3, 2025
Psychedelics American priest ousted by church for psilocybin advocacy He thinks magic mushrooms are spiritually elevating but his former religious overlords are not so enthused Rowan DunneSeptember 2, 2025
Psychedelics FDA gives another one of Filament Health’s psilocybin trials green light The news follows the agency approving a Phase 2 study on PEX010 for different indications in April Rowan DunneJuly 7, 2025
Psychedelics Texas makes its mark on psychedelics sector with US$50M in ibogaine research funding It's being called the largest publicly-funded psychedelic research initiative in history Rowan DunneMay 22, 2025
Medical and Pharmaceutical SILO Pharma flies high on impending patent for intranasal PTSD drug The stock rose by 146% in early morning trading on the Nasdaq Rowan DunneJanuary 8, 2025
AI and Autonomy The Best of 2024: A Mugglehead roundup The year’s economic landscape as 2024 comes to a close demonstrates the resilience and adaptability of key sectors Joseph MortonDecember 30, 2024
Psychedelics Not all Oregon cities approve of the state’s magic mushroom laws Four of them voted to implement new bans on usage of the psychedelic compound in the Nov. 5 election Rowan DunneNovember 22, 2024